D. Harris et al., Role of gap junctions in endothelium-derived hyperpolarizing factor responses and mechanisms of K+-relaxation, EUR J PHARM, 402(1-2), 2000, pp. 119-128
We have examined the effects of ouabain (1 mM), the gap junction inhibitors
, 18 alpha-glycyrrhetinic acid (100 mu M), N-(piperidin-1-yl)-5-(4-chloroph
enyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochlori
de (SR141716A; 10 mu M) and palmitoleic acid (50 mu M), and clotrimazole (1
0 mu M) against endothelium-derived hyperpolarizing factor (EDHF)-mediated
and K+-induced vasorelaxations in the rat mesentery. In the presence of ind
omethacin (10 mu M) and 300-mu M N(G)nitro-L-arginine methyl ester (L-NAME)
, carbachol caused EDHF-mediated relaxations (R-max = 85.3 +/- 4.0%). In th
e presence of ouabain, these responses were substantially reduced (R-max =
11.0 +/- 2.3%). 18 alpha-glycyrrhetinic acid, SR141716A, palmitoleic acid a
nd clotrimazole also significantly inhibited these EDHF-mediated responses.
K+ caused vasorelaxation of preparations perfused with K+-free buffer (R-m
ax = 73.7 +/- 2.4%), which were reduced by 10-mu M indomethacin (R-max = 56
.4 +/- 6.2%). K+ vasorelaxation was essentially abolished by endothelial de
nudation. Both ouabain and 18 alpha-glycyrrhetinic acid opposed K+ relaxati
ons, however, neither SR141716A, clotrimazole nor palmitoleic acid had any
effect. Direct cell-cell coupling via gap junctions was attenuated by ouaba
in, clotrimazole and palmitoleic acid. We conclude that: (i) that gap junct
ional communication plays a major role in EDHF-mediated relaxations, (ii) t
hat K+-vasorelaxation is endothelium-dependent (thus, K+ is unlikely to rep
resent an EDHF), and (iii) that the inhibitory actions of ouabain and clotr
imazole on gap junctions might contribute towards their effects against EDH
F. (C) 2000 Elsevier Science B.V. All rights reserved.